SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19
Br J Dermatol
.
2021 Jun;184(6):1194-1195.
doi: 10.1111/bjd.19833.
Epub 2021 Mar 4.
Authors
E Welsh
1
,
J A Cardenas-de la Garza
2
,
A Cuellar-Barboza
1
,
R Franco-Marquez
3
,
R I Arvizu-Rivera
4
Affiliations
1
Dermatology Service, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
2
Rheumatology Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
3
Pathology Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
4
Internal Medicine Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
PMID:
33511657
PMCID:
PMC8013476
DOI:
10.1111/bjd.19833
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Pityriasis Rosea* / diagnosis
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Urticaria* / diagnosis
Substances
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2